In this minisode, Mindy is joined by Vynamic’s Brian Schachter to discuss a few recent newsworthy items including: the Inflation Reduction Act signed by President Biden (00:50), the FDA granting Zynteglo a priority review (09:01), and the primary care market that is being reinvigorated by new entrants who are placing big bets on the healthcare system (14:40).

Podcast Tags: healthcare, healthcare news, life sciences, Inflation Reduction Act, Medicare, Zynteglo, primary care, value-based care, BlueBird Bio

Source Links:

· https://www.hhs.gov/about/news/2022/08/07/statement-by-hhs-secretary-xavier-becerra-on-senate-passage-of-the-inflation-reduction-act.html#:~:text=The%20Inflation%20Reduction%20Act%20locks,prescription%20drugs%20that%20they%20need.

· https://www.cnn.com/2022/08/07/politics/senate-democrats-climate-health-care-bill-vote/index.html

· https://www.cbsnews.com/news/insulin-price-cap-senate-republicans-block-inflation-reduction-act/

· https://www.google.com/search?q=FDA+to+approve+zynteglo&rlz=1C1GCEB_enUS943US943&oq=FDA+to+approve+zynteglo&aqs=chrome..69i57j33i160l2.3511j0j7&sourceid=chrome&ie=UTF-8

· https://endpts.com/bluebird-bio-may-finally-get-a-gene-therapy-approved-in-the-us/

· https://www.fiercepharma.com/pharma/cell-and-gene-therapy-makers-push-past-regulatory-payer-hurdles-to-set-up-high-hopes-for

· https://www.fiercehealthcare.com/providers/retailers-payers-and-startups-could-capture-30-primary-care-market-2030-report

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Mindy McGrath, Healthcare Industry Advisor

mindy.mcgrath@vynamic.com

Ryan Hummel, Executive and Head of Provider Sector

ryan.hummel@vynamic.com

Brian Schachter, Manager

brian.schachter@vynamic.com